
EDAP TMS S.A. EDAP
$ 3.34
1.37%
Quarterly report 2024-Q4
added 12-27-2025
EDAP TMS S.A. Interest Expense 2011-2026 | EDAP
Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.Includes:
- Interest on bank loans
- Interest on corporate bonds
- Interest on leases
- Interest on credit lines and overdrafts
High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.
Low interest expenses with high profits are a sign of financial stability.
Annual Interest Expense EDAP TMS S.A.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 232 K | 168 K | 52 K | 108 K | 165 K | 111 K | 44 K | 57 K | 64 K | -65 K | -1.97 M | -2.06 M | -875 K |
All numbers in EUR currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 232 K | -2.06 M | -305 K |
Interest Expense of other stocks in the Medical devices industry
| Issuer | Interest Expense | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Abiomed
ABMD
|
58.7 M | - | - | $ 17.2 B | ||
|
Allied Healthcare Products
AHPI
|
191 K | - | 3.58 % | $ 2.21 M | ||
|
Alphatec Holdings
ATEC
|
24.9 M | $ 20.75 | -1.38 % | $ 2.97 B | ||
|
Acutus Medical
AFIB
|
5.66 M | - | -26.83 % | $ 2.62 M | ||
|
Apyx Medical Corporation
APYX
|
2.48 M | $ 3.55 | 1.51 % | $ 123 M | ||
|
Cognyte Software Ltd.
CGNT
|
-1.61 M | $ 9.08 | -3.4 % | $ 652 M | ||
|
Boston Scientific Corporation
BSX
|
305 M | $ 94.69 | -0.71 % | $ 139 B | ||
|
Bio-Rad Laboratories
BIO
|
48.9 M | $ 303.92 | 0.16 % | $ 8.57 B | ||
|
Apollo Endosurgery
APEN
|
4.67 M | - | - | $ 475 M | ||
|
Conformis
CFMS
|
2.02 M | - | - | $ 16.4 M | ||
|
Cardiovascular Systems
CSII
|
1.63 M | - | 0.15 % | $ 844 M | ||
|
Cutera
CUTR
|
-244 K | - | -10.19 % | $ 1.99 M | ||
|
BioSig Technologies
BSGM
|
23 K | - | 37.08 % | $ 85.7 M | ||
|
Bruker Corporation
BRKR
|
-38.2 M | $ 48.19 | 2.28 % | $ 7.18 K | ||
|
Electromed
ELMD
|
78 K | $ 28.0 | -3.85 % | $ 237 M | ||
|
Eargo
EAR
|
549 K | - | - | $ 10.2 M | ||
|
Abbott Laboratories
ABT
|
376 M | $ 124.11 | -0.94 % | $ 216 B | ||
|
Second Sight Medical Products
EYES
|
1.19 M | - | -0.97 % | $ 54.4 M | ||
|
Neovasc
NVCN
|
133 K | - | - | $ 111 M | ||
|
IRadimed Corporation
IRMD
|
164 K | $ 97.29 | 0.01 % | $ 1.23 B | ||
|
Dynatronics Corporation
DYNT
|
410 K | - | 14.99 % | $ 929 K | ||
|
LivaNova PLC
LIVN
|
1.01 M | $ 61.59 | 0.1 % | $ 3.34 B | ||
|
LENSAR
LNSR
|
660 K | $ 11.58 | -0.43 % | $ 133 M | ||
|
Align Technology
ALGN
|
7.68 M | $ 156.27 | 0.08 % | $ 11.7 B | ||
|
Accuray Incorporated
ARAY
|
13 M | $ 0.85 | 3.12 % | $ 87.4 M | ||
|
Avinger
AVGR
|
1.72 M | - | -20.74 % | $ 369 K | ||
|
ClearPoint Neuro
CLPT
|
-40 K | $ 13.99 | 2.27 % | $ 378 M | ||
|
FONAR Corporation
FONR
|
347 K | $ 18.55 | -0.08 % | $ 122 M | ||
|
AxoGen
AXGN
|
-199 K | $ 31.21 | -4.64 % | $ 1.38 B | ||
|
Axonics Modulation Technologies
AXNX
|
-2.43 M | - | - | $ 3.31 B | ||
|
CONMED Corporation
CNMD
|
37.3 M | $ 40.78 | 0.49 % | $ 1.26 B | ||
|
OrthoPediatrics Corp.
KIDS
|
-1.07 M | $ 17.4 | -2.03 % | $ 402 M | ||
|
Globus Medical
GMED
|
2.2 M | $ 86.15 | -1.33 % | $ 11.7 B | ||
|
Integra LifeSciences Holdings Corporation
IART
|
3.94 M | $ 12.35 | -0.56 % | $ 951 M | ||
|
Aziyo Biologics
AZYO
|
5.8 M | - | 1.37 % | $ 20.5 M | ||
|
Myomo
MYO
|
21.1 K | $ 0.97 | 6.92 % | $ 6.84 M |